Showing 1 to 10 of 16 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
A Comprehensive and Observational Myeloproliferative
Neoplasms (MPN) Registry in the Province of Quebec
Registre des NMP (CINC424BCA04T)  Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Lambert Busque Michel-Olivier Gratton 514-252-3400 poste 2397 |
|
A Comprehensive and Observational Myeloproliferative
Neoplasms (MPN) Registry in the Province of Quebec
CINC424BCA04T Recruiting
|
CIUSSS DU NORD-DE-L'ILE-DE-MONTREAL
HOPITAL DU SACRE-COEUR-DE-MONTREAL
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Inès Chamakhi Caroline Chagnon 514-338-2222 poste 2818 |
|
A Comprehensive and Observational Myeloproliferative Neoplasms Registry in the Province of Quebec (MPN Registry)
Registre des NMP (CINC424BCA04T) Recruiting
|
CISSS DE LAVAL
HOPITAL DE LA CITE-DE-LA-SANTE
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Danielle Talbot Solange Tremblay 450-668-1010 poste 23603 |
|
A Comprehensive and Observational Myeloproliferative Neoplasms (MPN) Registry in the Province of Quebec
Registre des NMP (CINC424BCA04T) Recruiting
|
CISSS DE LA MONTEREGIE-CENTRE
HOPITAL CHARLES-LE MOYNE
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Pierre Desjardins Caroline Millette 450-466-5000 poste 3276 |
|
A Comprehensive and Observational Myeloproliferative Neoplasms (MPN) Registry in the Province of Quebec
Registre des NMP (CINC424BCA04T) Recruiting
|
CISSS DE CHAUDIERE-APPALACHES
HOTEL-DIEU DE LEVIS
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Danièle Marceau Pierre Bédard 418-835-7121 |
|
An exhaustive and observational register of myeloproliferative neoplasias in the province of Quebec (NPM Registry)
Registre des NMP (CINC424BCA04T) Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Harold J. Olney Julie Malo 514-890-8000 poste 23848 |
|
A Phase 3, Open-Label, Multicenter, Randomized, Active-controlled Study to Assess Pharmacokinetics and Compare the Efficacy, Safety, and Tolerability of P1101 vs Anagrelide as Second Line Therapy for Essential Thrombocythemia
SURPASS ET NCT04285086 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Shireen Sirhan Sarah Barnier 514-340-8222 poste 26394 |
|
A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis With Severe Thrombocytopenia (Platelet Count <50,000/?L)
PACIFICA NCT03165734 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Shireen Sirhan Sarah Barnier 514-340-8222 poste 26394 |
|
A Phase 3, Double-blind, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK Inhibitor Therapy and Who Require Red Blood Cell Transfusions
INDEPENDENCE (ACE-536-MF-002) NCT04717414 Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Lambert Busque Michaël Harnois 514-252-3400 poste 6288 |
|
A Multi-Country, Real-World Study to Explore Treatment Patterns, Effectiveness and Healthcare Resource Utilization for Patients Diagnosed With Myelofibrosis Through Chart Review
METER NCT05444972 Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Natasha Szuber |
Groupe d'étude en oncologie du Québec